Citation, DOI, disclosures and article data
Citation:
Gaillard F, Karnofsky performance status. Reference article, Radiopaedia.org (Accessed on 28 May 2023) https://doi.org/10.53347/rID-98727
Disclosures:
At the time the article was created Frank Gaillard had the following disclosures:
- Radiopaedia Australia Pty Ltd, Founder and CEO (ongoing)
- Biogen Australia Pty Ltd, Investigator-Initiated Research Grant for CAD software development in multiple sclerosis (past)
These were assessed during peer review and were determined to
not be relevant to the changes that were made.
View Frank Gaillard's current disclosures
Disclosures:
At the time the article was last revised Frank Gaillard had the following disclosures:
- Radiopaedia Australia Pty Ltd, Founder and CEO (ongoing)
- Biogen Australia Pty Ltd, Investigator-Initiated Research Grant for CAD software development in multiple sclerosis (past)
These were assessed during peer review and were determined to
not be relevant to the changes that were made.
View Frank Gaillard's current disclosures
The Karnofsky performance status (KPS) is a standardized measure of a patient’s ability to perform a variety of ordinary tasks. It is a score that ranges from 0 to 100 with a higher score indicating higher (less impaired) function. It is widely used in trials and allows for patient groups to be compared.
Scale
- 100: normal; no complaints; no evidence of disease
- 90: able to carry on normal activity; minor signs or symptoms of disease
- 80: normal activity with effort; some signs or symptoms of disease
- 70: cares for self; unable to carry on normal activity or to do active work
- 60: requires occasional assistance, but is able to care for most of their personal needs
- 50: requires considerable assistance and frequent medical care.
- 40: disabled; requires special care and assistance
- 30: severely disabled; hospital admission is indicated although death is not imminent
- 20: very sick; hospital admission necessary; active supportive treatment necessary
- 10: moribund; fatal processes progressing rapidly
- 0: dead
History and etymology
Karnofsky performance status was first published by David A. Karnofsky et al in 1948 as part of a paper on the efficacy of nitrogen mustards on carcinoma 1.
- 1. Karnofsky, D. A., Abelmann, W. H., Craver, L. F., & Burchenal, J. H. (1948). The use of the nitrogen mustards in the palliative treatment of carcinoma: With particular reference to bronchogenic carcinoma. Cancer, 1(4), 634–656. https://doi.org/10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L
Promoted articles (advertising)